Kim Trofimuk

First post: 10/24/2016 Latest post: 12/2/2016
 After losing our oldest sister to breast cancer at the age of 42, we became very proactive with our health.  We had genetic testing/counseling  that was negative 10 years ago.  Yearly mammograms and ultrasounds were routine until this year.  Kim had 2 areas of concern that were biopsied and fortunately were non cancerous.  It was then advised that she  repeat the genetic testing.   New genes had been discovered  over the last 10 years.  Two out of the three remaining sisters turned out to be positive for the Chek 2 gene, including Kim. This puts her risk of developing breast cancer as high as 48%.  Recommendations were MRI's alternating with mammograms every 6 months and being placed on raloxifene for the rest of her life.   The thought of going through the stress and anxiety twice a year, as well as taking a medication that increases your risk of developing  other types of cancers was just not an option.  Kim has courageously chosen to do a prophylactic mastectomy with reconstruction.  It may seem like an aggressive/ difficult decision but after watching her oldest sister die, her nephew grow up without his mom, and having children of her own, it was the only one. Kim's surgery is scheduled for October 28th. Todd will keep family and friends updated on her surgery and recovery thru caringbridge. 
Well wishes and prayers are welcomed.   We had many requests about providing a meal for her family.  If you would like to sign up for a day please click on  "ways to help" then click on  "our planner" you can chose a day without a name assigned.  Thank you for visiting her site.

CaringBridge is a nonprofit social network dedicated to helping family and friends communicate with and support loved ones during a health journey. Learn more about CaringBridge.

To interact with Kim’s website, sign in or register today.

By registering with CaringBridge, you will join over 300,000 people a day who are supporting friends and family members.

Sign In Or Register
SVG_Icons_Back_To_Top
Top